Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

NHS England

Artificial_Intelligence

AI in Healthcare and Digital Health Today—March 23, 2026

This week’s AI in Healthcare and Digital Health update highlights regulatory…

by Timos Papagatsias

Respiratory

Respiratory Weekly News—September 12th, 2025

This Week in Respiratory Health: Orphan Drugs, Asthma Campaigns, Phage Science,…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Respiratory Today—May 8, 2026
Vaccines Today—May 8, 2026
Public Health Today—May 8, 2026
Lucid Diligence Brief: Lucent Diagnostics and Tempus AI Partnership
Lucid Diligence Brief: Blackstone Life Sciences $250 million investment in Anagram Therapeutics

Tags

Acute Coronary Syndrome biomarker testing biotech incubator CAAS vFFR Chronic disease mortality conduction-system pacing consumer triage AI cost reduction Cytarabine DIPS Arena Enzalutamide FDA Digital Health Advisory FG001 GLP-1 Receptor Agonists gout flares Jaypirca Lamb-Shaffer Syndrome live biotherapeutic product LIVMARLI May Health MicroRNAs MIRACLE2 naxtarubicin NCEL-101 OCALIVA Office For Life Sciences PPMS provider strategy RCT-Twin-GAN Rinvoq Rituximab Spikevax Stanford Medicine Sutra Medical Tegoprubart TG Therapeutics Thailand Predictive Analytics Tivdak TLR7 TLX591-Tx Transgene UBT251 Ver-A-T1D Zydus ZYNTEGLO

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Respiratory Today—May 8, 2026
Vaccines Today—May 8, 2026
Public Health Today—May 8, 2026
Lucid Diligence Brief: Lucent Diagnostics and Tempus AI Partnership
Lucid Diligence Brief: Blackstone Life Sciences $250 million investment in Anagram Therapeutics

TAGS

Acute Coronary Syndrome biomarker testing biotech incubator CAAS vFFR Chronic disease mortality conduction-system pacing consumer triage AI cost reduction Cytarabine DIPS Arena Enzalutamide FDA Digital Health Advisory FG001 GLP-1 Receptor Agonists gout flares Jaypirca Lamb-Shaffer Syndrome live biotherapeutic product LIVMARLI May Health MicroRNAs MIRACLE2 naxtarubicin NCEL-101 OCALIVA Office For Life Sciences PPMS provider strategy RCT-Twin-GAN Rinvoq Rituximab Spikevax Stanford Medicine Sutra Medical Tegoprubart TG Therapeutics Thailand Predictive Analytics Tivdak TLR7 TLX591-Tx Transgene UBT251 Ver-A-T1D Zydus ZYNTEGLO

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy